Appetite Regulation : Semaglutide can reduce appetite, leading to decreased food intake and potential weight loss
Both GLP-1RAs and SGLT2-Is lower BP, reduce albuminuria, induce weight loss and improve glycaemic control, which all may contribute to their cardiorenal benefits [9, 10]
Many patients report reduced discomfort or improved function within 1-2 weeks
Research from the Employee Benefit Research Institute found that covering GLP-1s through insurance could raise employer premiums by as much as 14%, even when access was limited to the highest-need patients
Tirzepatide Side Effects: What You Need to Know Before Starting Key Highlights Tirzepatide is an injection used to treat Type 2 diabetes and help with weight loss
References View all 6 references + Pickart, L., & Thaler, M